Fosamax and Wasting - a phase IV clinical study of FDA data
Summary:
Wasting is reported as a side effect among people who take Fosamax (alendronate sodium), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Alendronate Sodium, and have High blood pressure.
The phase IV clinical study analyzes which people have Wasting when taking Fosamax. It is created by eHealthMe based on reports of 104,411 people who have side effects when taking Fosamax from the FDA, and is updated regularly.
What is Fosamax?
Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 105,451 Fosamax users. Check the latest studies of Fosamax.
What is Wasting?
Wasting (disease causes muscle and fat tissue to ""waste"" away) is found to be associated with 1,360 drugs and 1,928 conditions by eHealthMe. Check the latest studies of Wasting.
104,411 people reported to have side effects when taking Fosamax.
Among them, 249 people (0.24%) have Wasting.
Among these 249 people:
How long have people been on Fosamax when they have Wasting? *
What is the gender of people who have Wasting when taking Fosamax? *
What is the age of people who have Wasting when taking Fosamax? *
What are other drugs people take besides Fosamax? *
What are other side effects people have besides Wasting? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Fosamax and have Wasting?
- Check whether Wasting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Fosamax:
- Fosamax (105,451 reports)
Wasting treatments and more:
- Wasting (15,318 reports)
How severe was Wasting and when was it recovered:
Expand to all the drugs that have ingredients of alendronate sodium:
- Wasting and drugs with ingredients of alendronate sodium (306 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Fosamax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Wasting:
- Wasting (1,360 drugs)
Browse all the conditions that are associated with Wasting:
- Wasting (1,928 conditions)
Related publications that referenced our studies
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on alendronate sodium (the active ingredients of Fosamax) and Fosamax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Carvedilol and Losartan Potassium - 3 seconds ago
- Could Amitiza cause Primary Myelofibrosis? - 5 seconds ago
- Could Methotrexate cause Retroperitoneal Abscess? - 5 seconds ago
- Could Allopurinol cause Consciousness - Decreased? - 12 seconds ago
- Drug interactions of Clopra and Saphris - 19 seconds ago
- Drug interactions of Firazyr and Orladeyo - 20 seconds ago
- Could Clonazepam cause Metabolic Encephalopathy? - 23 seconds ago
- Could Aldactone cause Blood Bilirubin Abnormal? - 33 seconds ago
- Could Hydrocortisone cause Henoch-Schonlein Purpura? - 34 seconds ago
- Could Premarin cause Cartilage Injury? - 44 seconds ago